We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Jazmine N. Still
Jazmine N. Still
Products
PRODUCTS
Altaire Pharmaceuticals, Inc.
Bijoy Panicker
,
Jazmine N. Still
, and
Juanita P. Versace
Price:
$117.00
View
Ionetix Corp.
Jazmine N. Still
Price:
$117.00
View
Cosmax USA, Inc.
Jazmine N. Still
Price:
$117.00
View
Hospira, Inc.
Scott A. Golladay
,
Simone E. Pitts
, and
Jazmine N. Still
Price:
$117.00
View
Akron Coating & Adhesives, Inc.
Jazmine N. Still
Price:
$117.00
View
Buderer Drug Co.
Jazmine N. Still
Price:
$117.00
View
CIL Isotope Separations, LLC
Lauren N. Howard
and
Jazmine N. Still
Price:
$117.00
View
Buderer Drug Co., Inc.
Matthew Casale
and
Jazmine N. Still
Price:
$117.00
View
Gipsco Investment Corp. dba Lee Silsby Compounding Pharmacy
Matthew Casale
and
Jazmine N. Still
Price:
$117.00
View
RC Outsourcing
Matthew Casale
and
Jazmine N. Still
Price:
$117.00
View
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
25
Apr
A Masterclass on Effective 483 Responses
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Eugia Pharma Gets Three 483s Since January, Following Inspections of Plants in India
Abbott/Thoratec Heartmate LVAS Deaths Result in Class I Recall
EMA Releases Its New Real-World Evidence Capabilities to Researchers
Claims That Cardiac Device Grows New Arteries Get Devicemaker FDA Warning Letter
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More